Optimal designs for phase II clinical trials with heterogeneous patient populations
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - January 6, 2023 Category: Statistics Authors: Liu Cao Jung Source Type: research

Dynamic incorporation of real world evidence within the framework of adaptive design
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Lin Liao Gamalo-Siebers Source Type: research

Heterogeneous logistic regression for estimation of subgroup effects on hypertension
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Yan Wang Zhou Yan Wang Wang Xie Yang Zeng Chen Source Type: research

Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Li Tiwari Li Source Type: research

Fast tipping point sensitivity analyses in clinical trials with missing continuous outcomes under multiple imputation
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Gorst-Rasmussen Tarp-Johansen Source Type: research

Non-inferiority testing for qualitative microbiological methods:Assessing and improving the approach in USP
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: IJzerman-Boon Manju van den Heuvel Source Type: research

Bias and Type I error Control in Correcting Treatment Effect for Treatment Switching Using Marginal Structural Models in Phase III Oncology Trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Xu Liu Wang Source Type: research

Confidence interval construction for proportion difference from partially validated series with two fallible classifiers
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Qiu Wang Tang Poon Source Type: research

Survival stacking with multiple data types using pseudo-observation-based-AUC loss
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Ginestet Gabriel Sachs Source Type: research

Bayesian screening for feature selection
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Gould Baumgartner Zhao Source Type: research

Optimised point estimators for multi-stage single-arm phase II oncology trials
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Authors: Grayling Mander Source Type: research

Referees for Volume 32
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - December 30, 2022 Category: Statistics Source Type: research

Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - October 18, 2022 Category: Statistics Authors: Tang Yu Source Type: research

Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of caution
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - October 18, 2022 Category: Statistics Authors: Ong Wang Van der Elst Verbeke Molenberghs Alonso Source Type: research

A stochastically curtailed single & #8208;arm phase II trial design for binary outcomes
(Source: Journal of Biopharmaceutical Statistics)
Source: Journal of Biopharmaceutical Statistics - October 18, 2022 Category: Statistics Authors: Law Grayling Mander Source Type: research